Literature DB >> 20890887

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.

Alexander J Thompson, Andrew J Muir, Mark S Sulkowski, Keyur Patel, Hans L Tillmann, Paul J Clark, Susanna Naggie, Jacques Fellay, Dongliang Ge, Jeanette J McCarthy, David B Goldstein, John G McHutchison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890887     DOI: 10.1002/hep.23826

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infection.

Authors:  Alessio Aghemo
Journal:  Dig Dis Sci       Date:  2012-06-27       Impact factor: 3.199

2.  Drugs in development for viral hepatitis: care and caution.

Authors:  Paul J Pockros
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

3.  Natural history of HCV infection.

Authors:  Shiv K Sarin; Manoj Kumar
Journal:  Hepatol Int       Date:  2012-03-09       Impact factor: 6.047

Review 4.  Innate immunity: a new chapter for hepatitis C.

Authors:  Theresa Hydes; Salim I Khakoo
Journal:  Ann Gastroenterol       Date:  2012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.